BEIJBS:AQUISEUBeijer Ref AB Class B Analysis
Data as of 2026-06-17 - not real-time
SEK 130.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Beijer Ref is trading very close to its short‑term moving average, with the 20‑day SMA acting as a near‑term support level. The MACD histogram remains positive, suggesting underlying bullish momentum, while the RSI hovers around a neutral zone, indicating no immediate overbought or oversold pressure. Market sentiment is exceptionally optimistic, as reflected by an “Extreme Greed” reading on the fear‑and‑greed index.
Fundamentally, the company reports a modest profit margin and solid cash generation, but revenue is contracting and valuation metrics place the stock well above its discounted cash‑flow fair value. The balance sheet shows a moderate debt load relative to equity, and the absence of a dividend eliminates income‑focused appeal. Volatility has risen above 15% in the past month, and trading volume is below average, pointing to heightened price swings and limited liquidity.
Fundamentally, the company reports a modest profit margin and solid cash generation, but revenue is contracting and valuation metrics place the stock well above its discounted cash‑flow fair value. The balance sheet shows a moderate debt load relative to equity, and the absence of a dividend eliminates income‑focused appeal. Volatility has risen above 15% in the past month, and trading volume is below average, pointing to heightened price swings and limited liquidity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near 20‑day SMA support
- positive MACD histogram
- low trading volume increasing price fragility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- stock trading below 50‑day and 200‑day SMAs
- valuation significantly above DCF fair value
- negative revenue growth despite stable cash flow
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- steady profitability with modest ROE
- moderate debt‑to‑equity ratio
- lack of dividend and limited upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth-3.90%
Profit Margin6.33%
P/E Ratio28.5
ROE10.37%
ROA4.61%
Debt/Equity58.05
P/B Ratio2.9
Op. Cash FlowSEK4.1B
Free Cash FlowSEK2.1B
Industry P/E31.6
Technical Analysis
TrendBearish
RSI49.1
SupportSEK 125.90
ResistanceSEK 140.55
MA 20SEK 130.47
MA 50SEK 132.53
MA 200SEK 141.71
MACDBullish
VolumeIncreasing
Fear & Greed Index91.41
Valuation
Fair ValueSEK 32.89
GradeOvervalued
TypeValue
Risk Assessment
Beta0.20
Volatility15.90%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.